• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Walmart (WMT)

Walmart store in south San Francisco bay area
Sundry Photography/Shutterstock

Bridgewater owns more than five million shares of retail giant Walmart, representing about 3.8% of its portfolio, making it the hedge fund’s fifth-largest holding.

While inflation stinks for consumers, having a stake in a company that places emphasis on “everyday low prices” for goods they can’t do without isn’t a bad position to be in as an investor.

Sure, Walmart is itself paying more for goods and struggling with the same supply chain issues all retailers are. But the discount gorilla is in a perfect position to take market share away from competitors as consumers flock to their aggressively low prices.

In the most recent quarter, Walmart’s U.S. same-store sales — a key measure of a retailer’s health — increased an impressive 9.2%.

Shares of Walmart are down 5% over the past three months, giving contrarian investors something to think about.

Trading Tips for All Levels: Avoid These 5 Expensive Mistakes

Don't let costly errors derail your trading success. Learn about the five most expensive mistakes in options trading and how to avoid them, whether you're just starting out or have years of experience. Enhance your trading strategy today and stay ahead of the game!

Learn More

Pepsico (PEP)

Cans of Pepsi with water drops on black table
New Africa/Shutterstock

Almost 2.7 million Pepsico shares take up space in the Bridgewater portfolio, accounting for 2.2% of the fund.

A Pepsico play puts investors on the right side of higher priced consumer staples. In the most recent quarter, the beverage and snack giant posted solid double-digit sales on volume growth as well as price increases.

While main rival Coca-Cola is also a fine way to play defense (Ray Dalio owns it, as well), Pepsico’s broad product offering is a more diversified way to battle against higher prices.

In addition to a sprawling selection of popular colas, juices, sports drinks and bottled waters, Pepsico is all over the salty snack market. Lay’s, Fritos, Smartfood Popcorn, Doritos and Chitos are all theirs. The company also owns the Quaker line of cereals, rice snacks and baking mixes.

Good luck finding many households in America that don’t have at least one Pepsi product in them.

Pepsico shares are up 12% in 2021 and trade at $162 apiece. If that’s too steep, you can always use a popular investing app to buy fractions of shares with as much money as you are willing to spend.

Johnson & Johnson (JNJ)

Johnson & Johnson Inc. logo at the Markham office building.
CCPang/Shutterstock

If you purchased Johnson & Johnson because of the company’s COVID-19 vaccine, here’s hoping you haven’t already offloaded it to go chasing high-flying momentum stocks.

Bridgewater still owns 2.75 million shares of J&J, representing 2.4% of the hedge fund’s portfolio.

J&J isn’t just a drug maker.

Like Pepsico, Johnson & Johnson boasts consumer staples found in any U.S. home: skin care products like Neutrogena, pain medications Tylenol and Motrin, Listerine, Band-Aids, and more.

In fact, Johnson & Johnson recently announced plans to spin off its consumer health segment into a separate company in order to unlock value. Once the split is complete, investors will be given shares in both companies and, in turn, receive dividend payments from both stocks.

That makes J&J a particularly timely and attractive inflation play.

Follow These Steps Once Your Portfolio Reaches $150K

If you've amassed a $150k+ portfolio, it's time to meet with a trusted advisor. Zoe Financial helps you connect with fiduciary advisors to grow your wealth. Find, hire, and invest with vetted financial advisors tailored to your unique situation.

With Zoe Financial, find your top 3 advisor matches, book a free initial consultation, and pick your favorite advisor.

Get Started

A real hedge against inflation

rear view of younga caucasian woman stading in an art gallery in front of two large colorful paintings
Comaniciu Dan/Shutterstock

When inflation is raging, stocks aren’t always an investor’s best friend.

Opting for more tangible assets can sometimes better preserve the value of an investment.

If real assets are more your speed, it might be time to dip into the contemporary art market, which has outperformed the S&P 500 by an impressive 174% since 1995.

Don’t worry. You won’t have to rent a tux and outbid a roomful of millionaires.

A popular investing platform helps you purchase shares in modern masterpieces, allowing you to secure a stake in rapidly appreciating works by Banksy, Monet and even Andy Warhol.

You won’t have them on your wall, but you will have them in your portfolio, where they can be just as pretty.

Sponsored

This 2 Minute Move Could Knock $500/Year off Your Car Insurance in 2024

Saving money on car insurance with BestMoney is a simple way to reduce your expenses. You’ll often get the same, or even better, insurance for less than what you’re paying right now.

There’s no reason not to at least try this free service. Check out BestMoney today, and take a turn in the right direction.

Clayton Jarvis is a mortgage reporter at MoneyWise. Prior to joining the MoneyWise team, Clay wrote for and edited a variety of real estate publications, including Canadian Real Estate Wealth, Real Estate Professional, Mortgage Broker News, Canadian Mortgage Professional, and Mortgage Professional America.

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.